Filing Flows › Comparisons › GILD vs MRNA
Gilead Sciences vs Moderna: GILD and MRNA compared
Gilead Sciences is the larger company: $8.3B of revenue in its latest quarter (Q3 2026) against $1.3B for Moderna (Q3 2026). Moderna is growing faster (+29% against +7% a year earlier). Gilead Sciences is more profitable, with an operating margin of 41.7% against 9.9%.
Where the money goes: GILD and MRNA
Gilead Sciences (GILD) · Q3 2026
Gilead Sciences, Q3 2026: revenue $8.3B (+7% year over year), operating margin 41.7%, net earnings $2.4B, operating cash flow $5.0B. The chart follows the revenue to costs, profit and cash.
Moderna (MRNA) · Q3 2026
Moderna, Q3 2026: revenue $1.3B (+29% year over year), operating margin 9.9%, net earnings $162M, operating cash flow −$1.6B. The chart follows the revenue to costs, profit and cash.
| Gilead Sciences (GILD) | Moderna (MRNA) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $8.3B | $1.3B |
| Revenue growth, Y/Y | +7% | +29% |
| Operating margin | 41.7% | 9.9% |
| Net earnings | $2.4B | $162M |
| Net margin | 29.3% | 12.3% |
| Operating cash flow | $5.0B | −$1.6B |
| Free cash flow | $4.8B | — |
| Market value | $209.6B | $109.3B |
| Analysts’ mean target | $174.77 | $145.42 |
Where the revenue comes from
Gilead Sciences
- Total HIV: $6.3B (76%)
- Trodelvy: $506M (6%)
- Total Cell Therapy: $355M (4%)
- Genvoya: $339M (4%)
Moderna
- Net product sales: $1.3B (97%)
- RSV: $29.0M (2%)
- Collaboration Arrangement, Including Arrangements with Affiliate: $8.0M (1%)
Questions
Which is bigger, Gilead Sciences or Moderna?
Gilead Sciences is the larger company: $8.3B of revenue in its latest quarter (Q3 2026) against $1.3B for Moderna (Q3 2026).
Is Gilead Sciences or Moderna growing faster?
Moderna is growing faster (+29% against +7% a year earlier).
Which is more profitable, Gilead Sciences or Moderna?
Gilead Sciences is more profitable, with an operating margin of 41.7% against 9.9%.
More: Gilead Sciences earnings · how Gilead Sciences makes money · Moderna earnings · how Moderna makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 30, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.